The city of Salt Lake City, Utah, currently has 6 active clinical trials seeking participants for Healthy research studies.
Single and Multiple Ascending Dose Study and Food Effect Study for AG181
NCT06286033
Recruiting
The primary purpose of this study is to assess the safety and tolerability of AG-181 in healthy participants after oral administration of single ascending dose (SAD) of AG-181 in Part 1 and multiple ascending dose (MAD) in Part 2 along with the effect of food on the pharmacokinetics (PK) of single oral doses of AG-181 in healthy participants in Part 3.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
03/27/2025
Locations: ICON 1255 East 3900 South, Salt Lake City, Utah
Conditions: Healthy Volunteers
Register for Updates
A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants
NCT06813924
Recruiting
The study aims to test if a new medicine called etavopivat potentially affects other medicines in healthy participants. The purpose of the study is to investigate whether the use of etavopivat affects the breakdown and metabolism of commonly used medicines in the body. During the study, participants will receive etavopivat and five different medicines that are already approved and available on the market, and which can be prescribed by doctors. These marketed medicines are called substrate drugs... Read More
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
03/20/2025
Locations: ICON-Salt Lake City, Salt Lake City, Utah
Conditions: Healthy Volunteers Sickle Cell Disease, Thalassemia
Register for Updates
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants
NCT06746402
Recruiting
The purpose of this study is to determine the safety, tolerability, and pharmacokinetics (PK) of high dose of BMS-986278 in healthy participants and to assess the effect of BMS-986278 on the ECG intervals in healthy participants.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
03/07/2025
Locations: ICON Salt Lake City, Salt Lake City, Utah
Conditions: Healthy Volunteers
Register for Updates
A First-In-Human Study of LY3985297 in Healthy Participants
NCT06395012
Recruiting
The main purpose of this study is to see if LY3985297, the study drug, is safe and well-tolerated when given as a single dose or as multiple doses either through an intravenous (into a vein) or a subcutaneous (under the skin) injection in healthy participants. Study will also evaluate how much of the study drug LY3985297 gets into the blood stream and how long it takes the body to remove it. The study is conducted in two parts (part A and B), each part has a separate treatment cohort. The stud... Read More
Gender:
ALL
Ages:
Between 18 years and 64 years
Trial Updated:
02/27/2025
Locations: ICON, Salt Lake City, Utah
Conditions: Healthy
Register for Updates
Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets
NCT06801418
Recruiting
This is a study to evaluate bioequivalence between adagrasib reference tablets and high drug load tablets in healthy adult participants.
Gender:
ALL
Ages:
Between 18 years and 60 years
Trial Updated:
02/25/2025
Locations: ICON - Salt Lake City, Salt Lake City, Utah
Conditions: Healthy Volunteers
Register for Updates
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
NCT04143659
Recruiting
This is a Phase I multicenter, open-label, dose-ranging, three-dose PK and PD study of injectable LB administered as an IM or SQ injection at 40 mg, and subsequently at 50mg SQ and then 60 mg SQ depending on the preliminary pharmacokinetic and pharmacodynamic results obtained with 40 mg dosing.
Gender:
FEMALE
Ages:
Between 18 years and 40 years
Trial Updated:
08/11/2023
Locations: University of Utah, Salt Lake City, Utah
Conditions: Healthy Women, Female Contraception
Register for Updates